Search results
Thurs Blogcast: Coin envy; Denver homeless policy; Carville breakdown | iHeart
iHeartRadio· 6 days agoEarlier this week, President Biden announced tariffs on a bunch of imports from China. While most of...
Judge Dismisses FTC Case Against Welsh Carson but Enforcement Focus on Private Equity in Health Care...
The National Law Review· 13 hours agoOn 13 May, a federal district court judge dismissed the Federal Trade Commission’s (FTC) antitrust...
Senators call for federal inquiry over barring Andretti team from Formula One
UPI· 13 hours ago1 of 5 | Sen. Debbie Stabenow (L), D-Mich., speaks as Sen. Amy Klobuchar, D-Minn. , looks on during...
Joe Biden asked to investigate Formula 1
Newsweek· 22 hours agoPresident Joe Biden has been asked to investigate Formula 1 over its decision to reject Andretti Global. According to NBC News, a bipartisan group of...
DOJ antitrust chief touts blocked mergers
The Hill via Yahoo Finance· 14 hours agoJustice Department antitrust division chief Jonathan Kanter praised his agency’s record of stopping mergers in concentrated markets Tuesday amid ongoing...
Justice Department's Antitrust Chief Celebrates Merger Stoppages
PYMNTS.com· 11 hours agoJonathan Kanter, the head of the Justice Department’s antitrust division, has applauded his agency’s...
Senators call on Justice Department and FTC to investigate Formula 1 for rejecting Andretti Global
NBC News via Yahoo Sports· 15 hours agoIn a letter led by Democratic Sen. Amy Klobuchar, chair of the Senate antitrust panel, six senators...
Senators call for investigation of F1's rejection of Andretti Global
New York Times· 17 hours agoSix U.S. senators have called for the Department of Justice and the Federal Trade Commission to...
D.C. is testing its Big Tech antitrust campaign far from D.C.
Yahoo Finance· 6 days agoNo longer is the nation’s capital always the trial venue of choice for the Justice Department and...
FTC targets 300 Big Pharma 'junk patents,' sends warning letters to top drugmakers
BenefitsPRO· 7 days ago"By filing bogus patent listings, pharma companies block competition and inflate the cost of...
